COMP <GO>
CGEN vs DTIL // REVENUE GROWTH (YOY)
Compugen Ltd. (NASDAQ) VS. Precision BioSciences Inc. (NASDAQ) • 15-METRIC TALLY: CGEN 5
— DTIL 2
▲ REVENUE GROWTH (YOY) LEADER: CGEN
LAST: $1.98 (-2.94%) • MKT CAP: $193.0M
revenue-growth
161.10%
LAST: $7.06 (-5.11%) • MKT CAP: $205.4M
revenue-growth
-50.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CGEN VS. DTIL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CGEN | DTIL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 87.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | -35.00% | +120.00 | CGEN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 3.2x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 16.24% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 43.10% | -60.00% | +103.10 | CGEN | /operating-margins <GO> |
| Net Profit Margin | 48.60% | -60.00% | +108.60 | CGEN | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 161.10% | -50.10% | +211.20 | CGEN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 1/9 | +6.00 | CGEN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.1 | 55.8 | -14.68 | DTIL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 4.6x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $193.0M | $205.4M | -$12.4M | DTIL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CGEN REV | DTIL REV | CGEN GROSS % | DTIL GROSS % | CGEN FCF | DTIL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $72.8M | $34.3M | 87.3% | — | $31.3M | -$65.8M |
| FY 2024 | $27.9M | $68.7M | 71.5% | — | $49.5M | -$58.4M |
| FY 2023 | $33.5M | $48.7M | — | — | -$35.9M | -$84.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CGEN // BETA —
DTIL // BETA —